First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Trading Down 1.8% – Time to Sell?

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)’s share price traded down 1.8% during mid-day trading on Monday . The company traded as low as $209.41 and last traded at $209.43. 51,636 shares traded hands during mid-day trading, an increase of 147% from the average session volume of 20,888 shares. The stock had previously closed at $213.21.

First Trust NYSE Arca Biotechnology Index Fund Stock Down 1.8%

The business’s 50-day moving average price is $196.31 and its 200 day moving average price is $177.77. The company has a market capitalization of $1.27 billion, a P/E ratio of 21.72 and a beta of 0.65.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Harbour Investments Inc. grew its position in First Trust NYSE Arca Biotechnology Index Fund by 1.2% during the second quarter. Harbour Investments Inc. now owns 5,767 shares of the company’s stock worth $930,000 after buying an additional 69 shares in the last quarter. Concurrent Investment Advisors LLC boosted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 5.1% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 1,746 shares of the company’s stock valued at $282,000 after acquiring an additional 85 shares during the last quarter. Stratos Wealth Partners LTD. grew its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 3.8% during the second quarter. Stratos Wealth Partners LTD. now owns 1,621 shares of the company’s stock worth $262,000 after purchasing an additional 60 shares in the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 4.3% during the second quarter. Envestnet Asset Management Inc. now owns 120,485 shares of the company’s stock worth $19,438,000 after purchasing an additional 4,945 shares in the last quarter. Finally, Holistic Financial Partners increased its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 209.5% in the second quarter. Holistic Financial Partners now owns 17,922 shares of the company’s stock worth $2,891,000 after purchasing an additional 12,131 shares during the last quarter.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.